REG - GlaxoSmithKline PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">GSK.L</Origin>

GSKAnnouncement

16/10/2017 16:45

RNS Number : 7382T
GlaxoSmithKline PLC
16 October 2017
GlaxoSmithKline plc(the'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr S Dexter
b)
Position/status
PCA of Dr P J T Vallance (President, R&D)
c)
Initial notification/
amendment
Initial notification
2. 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name 
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Descriptionofthefinancial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Natureofthetransaction
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 October 2017.
c)
Price(s)and 
volume(s)
Price(s)
Volume(s)
15.2748
395
d)
Aggregatedinformation
AggregatedvolumePrice
n/a (single transaction)
e)
Date ofthetransaction
2017-10-12
f)
Placeofthe transaction
London Stock Exchange (XLON)

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHEQLFFDBFZFBF